Simon M. Laws
Cited by
Cited by
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture
Q Zhang, J Sidorenko, B Couvy-Duchesne, RE Marioni, MJ Wright, ...
Nature communications 11 (1), 4799, 2020
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription
SM Laws, E Hone, S Gandy, RN Martins
Journal of neurochemistry 84 (6), 1215-1236, 2003
The role of beta amyloid in Alzheimer’s disease: still a cause of everything or the only one who got caught?
G Verdile, S Fuller, CS Atwood, SM Laws, SE Gandy, RN Martins
Pharmacological Research 50 (4), 397-409, 2004
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ...
Molecular psychiatry 18 (8), 875-881, 2013
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a …
SC Burnham, P Bourgeat, V Doré, G Savage, B Brown, S Laws, P Maruff, ...
The Lancet Neurology 15 (10), 1044-1053, 2016
Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging
VB Gupta, SM Laws, VL Villemagne, D Ames, AI Bush, KA Ellis, JK Lui, ...
Neurology 76 (12), 1091-1098, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study
KE Pike, KA Ellis, VL Villemagne, N Good, G Chételat, D Ames, C Szoeke, ...
Neuropsychologia 49 (9), 2384-2390, 2011
Examination of the current top candidate genes for AD in a genome-wide association study
TM Feulner, SM Laws, P Friedrich, S Wagenpfeil, SHR Wurst, C Riehle, ...
Molecular psychiatry 15 (7), 756-766, 2010
Plasma amyloid-β as a biomarker in Alzheimer's disease: the AIBL study of aging
JK Lui, SM Laws, QX Li, VL Villemagne, D Ames, B Brown, AI Bush, ...
Journal of Alzheimer's disease 20 (4), 1233-1242, 2010
The relationship between sleep quality and brain amyloid burden
BM Brown, SR Rainey-Smith, VL Villemagne, M Weinborn, RS Bucks, ...
Sleep 39 (5), 1063-1068, 2016
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
A Rembach, NG Faux, AD Watt, KK Pertile, RL Rumble, BO Trounson, ...
Alzheimer's & Dementia 10 (1), 53-61, 2014
Aβ-amyloid and tau imaging in dementia
VL Villemagne, V Dore, P Bourgeat, SC Burnham, S Laws, O Salvado, ...
Seminars in nuclear medicine 47 (1), 75-88, 2017
APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease
YY Lim, VL Villemagne, SM Laws, RH Pietrzak, PJ Snyder, D Ames, ...
Molecular psychiatry 20 (11), 1322-1328, 2015
BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease
YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ...
Neurobiology of aging 34 (11), 2457-2464, 2013
Olfactory discrimination predicts cognitive decline among community-dwelling older adults
HR Sohrabi, KA Bates, MG Weinborn, ANB Johnston, A Bahramian, ...
Translational psychiatry 2 (5), e118-e118, 2012
Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease
G Verdile, SM Laws, D Henley, D Ames, AI Bush, KA Ellis, NG Faux, ...
Molecular psychiatry 19 (1), 69-75, 2014
Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies
RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ...
Journal of Alzheimer's Disease 62 (3), 965-992, 2018
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults
YY Lim, KA Ellis, RH Pietrzak, D Ames, D Darby, K Harrington, RN Martins, ...
Neurology 79 (16), 1645-1652, 2012
The system can't perform the operation now. Try again later.
Articles 1–20